Skip to main
ADNT

Adient (ADNT) Stock Forecast & Price Target

Adient (ADNT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 25%
Buy 13%
Hold 50%
Sell 13%
Strong Sell 0%

Bulls say

Adient's fiscal 2025 consolidated revenue reached $14.5 billion, marking a significant financial milestone following the company's spin-off from Johnson Controls. The company holds approximately a mid-teens share of the global seating market and anticipates further share gains through onshored production initiatives, with targeted programs potentially doubling revenue contributions from those areas. Furthermore, management projects margin expansion to between 5.0% and 5.5% over the next two to three years, indicating improved profitability and operational efficiency.

Bears say

Adient faces ongoing challenges stemming from legacy issues, including loss-making metals contracts and uncompetitive plants, which have significantly depressed profitability and cash flow since the spin-off. The company is also experiencing adverse conditions in the EMEA region, characterized by lower vehicle production and an unfavorable production mix, further impacting revenue generation. In addition, persistent geopolitical and macroeconomic headwinds are anticipated to continue straining production capabilities in Europe.

Adient (ADNT) has been analyzed by 8 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 13% recommend Buy, 50% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adient and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adient (ADNT) Forecast

Analysts have given Adient (ADNT) a Hold based on their latest research and market trends.

According to 8 analysts, Adient (ADNT) has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adient (ADNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.